Over 18 years of product development experience in multiple therapeutic classes with the last 8 years being focused exclusively in dermatology. Served as Vice President of Medical Strategy and Scientific Affairs at LEO Pharma, Inc. responsible for all post-marketing medical support to the company’s product lines in actinic keratosis and psoriasis. Responsible for the late-stage clinical development of Enstilar® aerosol foam, and for the first wave of follow-on global approvals of Picato®. Also served as Director, Clinical Operations – The Americas, Vice President of LEO Project Management, and Director of Preclinical Development, all at LEO Pharma with the latter two being based in LEO Pharma’s Danish HQ. Iain’s career began at the preclinical CRO, Inveresk Research (now Charles River) as a Senior Study Director, and following this spent 7 years working in oncology and auto-immune diseases at Cyclacel, Inc. in various roles culminating in Project Manager, Pharmaceutical Development. Iain has a PhD and 1st Class Honors BSc. in Chemistry from Glasgow Caledonian University and was a Post-doctoral Fellow in Medicinal Chemistry at the University of Strathclyde.

 Clinical development of drugs